These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22214886)

  • 1. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to rotavirus vaccination quality measures in a commercially insured population.
    Eisenberg DF; Gu T; Krishnarajah G
    Hum Vaccin Immunother; 2013 Feb; 9(2):389-97. PubMed ID: 23291933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants.
    Macías-Parra M; Vidal-Vázquez P; Reyna-Figueroa J; Rodríguez-Weber MÁ; Moreno-Macías H; Hernández-Benavides I; Fortes-Gutiérrez S; Richardson VL; Vázquez-Cárdenas P
    Front Public Health; 2024; 12():1356932. PubMed ID: 38463163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of Rotavirus Vaccine Doses and Severe Rotavirus Gastroenteritis Among Vaccinated Infants in Low- and Middle-income Countries.
    Gruber JF; Becker-Dreps S; Hudgens MG; Brookhart MA; Thomas JC; Jonsson Funk M
    Epidemiology; 2018 Nov; 29(6):867-875. PubMed ID: 30074540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.
    Velázquez RF; Linhares AC; Muñoz S; Seron P; Lorca P; DeAntonio R; Ortega-Barria E
    BMC Pediatr; 2017 Jan; 17(1):14. PubMed ID: 28086819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccination and short-term risk of adverse events in US infants.
    Layton JB; Butler AM; Panozzo CA; Brookhart MA
    Paediatr Perinat Epidemiol; 2018 Sep; 32(5):448-457. PubMed ID: 30048564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the Effectiveness of Rotavirus Vaccine Schedules.
    Butler AM; Breskin A; Sahrmann JM; Brookhart MA
    Epidemiology; 2021 Jul; 32(4):598-606. PubMed ID: 33927157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study.
    Bar-Zeev N; King C; Phiri T; Beard J; Mvula H; Crampin AC; Heinsbroek E; Lewycka S; Tate JE; Parashar UD; Costello A; Mwansambo C; Heyderman RS; French N; Cunliffe NA;
    Lancet Glob Health; 2018 Sep; 6(9):e1036-e1044. PubMed ID: 30103981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016.
    Haber P; Amin M; Ng C; Weintraub E; McNeil MM
    Hum Vaccin Immunother; 2018; 14(11):2755-2759. PubMed ID: 29993327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccines WHO position paper: January 2013 - Recommendations.
    Vaccine; 2013 Dec; 31(52):6170-1. PubMed ID: 23746456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco.
    Mohy A; Lagoubi Y; Gomez JA; Amadou B; Bouskraoui M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2353480. PubMed ID: 38757507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.
    Gomez J; Velázquez FR; Guzman-Holst A; Cervantes Apolinar MY; Van Bellinghen LA; Van Vlaenderen I; van Oorschot D
    Hum Vaccin Immunother; 2023 Aug; 19(2):2219189. PubMed ID: 37339232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence.
    Martinelli D; Fortunato F; Marchetti F; Prato R
    Hum Vaccin Immunother; 2021 May; 17(5):1546-1551. PubMed ID: 32946314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccination in the US: a systematic review of vaccination coverage and completion.
    Ghaswalla PK; D'Angelo J; Abu-Elyazeed R
    Hum Vaccin Immunother; 2021 Mar; 17(3):872-879. PubMed ID: 32845792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluation of Human Rotavirus Vaccine in Thailand.
    Saokaew S; Prasitsuebsai W; Bibera GL; Kengkla K; Zhang XH; Oh KB; Lee C
    Infect Dis Ther; 2019 Sep; 8(3):397-415. PubMed ID: 31197662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines.
    Luna-Casas G; Juliao P; Carreño-Manjarrez R; Castañeda-Prado A; Cervantes-Apolinar MY; Navarro-Rodriguez R; Sánchez-González G; Cortés-Alcalá R; DeAntonio R
    Hum Vaccin Immunother; 2019; 15(6):1251-1259. PubMed ID: 30380975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    Wilson SE; Chung H; Schwartz KL; Guttmann A; Deeks SL; Kwong JC; Crowcroft NS; Wing L; Tu K
    PLoS One; 2018; 13(2):e0192809. PubMed ID: 29444167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccination rate disparities seen among infants with acute gastroenteritis in Georgia.
    Parker TC; Mohammed A; Leong T; Mays S; Jain S; Churchill V; Ali F; Immergluck LC
    Ethn Health; 2017 Dec; 22(6):585-595. PubMed ID: 27741577
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.